MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on HealthSpring Extra Rx (S5617-371)

Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Louisiana
Premium
$60.60/month
Deductible
$615.00, doesn't apply to tier 1 and 2
Change plan

1 of 8 Multiple sclerosis drugs is covered on this plan. It requires prior authorization.

7 aren't on the formulary, including Kesimpta and teriflunomide.

Not on the formulary
Kesimpta, teriflunomide, Vumerity, fingolimod, Mayzent, Zeposia, Mavenclad

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list